Teva Appoints Strategy and Innovation BD

Timothy R. Wright has been appointed head of business development, strategy and innovation, Teva Pharmaceutical Industries Ltd. He joins the executive leadership team, reporting to the president and chief executive officer, Erez Vigodman. Mr. Wright will be responsible for identifying new sources of innovation and growth that are extensions of the company’s business model.
 
“The addition of Tim to our leadership team complements the strong management capabilities we have in Teva. He has a wealth of global experience which will serve us well as we look to create a new and exciting future for Teva,” said Erez Vigodman, Teva’s president and chief executive officer. “Tim is known for leading the transformation of large companies. His significant experience across various aspects of healthcare and unique perspective will enable us to realize our full potential at this critical time of change in the pharmaceutical industry.”